VACCA, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 41.361
AS - Asia 16.224
EU - Europa 15.313
SA - Sud America 4.299
AF - Africa 756
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 22
Totale 78.011
Nazione #
US - Stati Uniti d'America 40.686
SG - Singapore 6.876
IT - Italia 5.330
CN - Cina 3.639
BR - Brasile 3.444
SE - Svezia 2.178
HK - Hong Kong 2.021
RU - Federazione Russa 1.479
DE - Germania 1.476
FR - Francia 1.036
UA - Ucraina 1.002
FI - Finlandia 968
VN - Vietnam 946
GB - Regno Unito 880
IN - India 523
BD - Bangladesh 514
CA - Canada 330
AR - Argentina 278
IQ - Iraq 217
ID - Indonesia 215
ZA - Sudafrica 191
MX - Messico 175
TR - Turchia 166
CI - Costa d'Avorio 164
JP - Giappone 153
CO - Colombia 141
PK - Pakistan 140
BE - Belgio 136
PL - Polonia 128
NL - Olanda 127
VE - Venezuela 115
EC - Ecuador 110
IE - Irlanda 109
ES - Italia 106
UZ - Uzbekistan 104
SA - Arabia Saudita 101
MA - Marocco 94
PH - Filippine 93
TN - Tunisia 66
AT - Austria 65
CL - Cile 64
CZ - Repubblica Ceca 59
LT - Lituania 56
MY - Malesia 56
JO - Giordania 53
AE - Emirati Arabi Uniti 50
KE - Kenya 49
EG - Egitto 43
JM - Giamaica 39
PY - Paraguay 39
UY - Uruguay 36
KR - Corea 33
BO - Bolivia 32
NP - Nepal 32
PE - Perù 31
ET - Etiopia 30
IR - Iran 30
AU - Australia 28
AL - Albania 27
OM - Oman 27
LB - Libano 26
IL - Israele 25
RS - Serbia 25
AZ - Azerbaigian 23
PS - Palestinian Territory 23
DZ - Algeria 22
CH - Svizzera 21
TT - Trinidad e Tobago 20
KG - Kirghizistan 19
PA - Panama 18
TH - Thailandia 18
SN - Senegal 17
CR - Costa Rica 15
KZ - Kazakistan 15
EU - Europa 14
HN - Honduras 14
BH - Bahrain 13
DO - Repubblica Dominicana 12
PT - Portogallo 12
GT - Guatemala 11
QA - Qatar 11
RO - Romania 11
BY - Bielorussia 10
NG - Nigeria 10
TW - Taiwan 10
GR - Grecia 9
NI - Nicaragua 9
GE - Georgia 8
KW - Kuwait 8
LY - Libia 8
MK - Macedonia 8
AO - Angola 7
NO - Norvegia 7
SV - El Salvador 7
AM - Armenia 6
BB - Barbados 6
BG - Bulgaria 6
EE - Estonia 6
DK - Danimarca 5
MT - Malta 5
Totale 77.856
Città #
Fairfield 4.238
Ashburn 4.193
Singapore 3.747
Chandler 3.313
Woodbridge 3.078
Jacksonville 2.208
San Jose 2.174
Hong Kong 2.007
Houston 1.956
Milan 1.786
Seattle 1.777
Cambridge 1.589
Nyköping 1.467
Wilmington 1.417
Ann Arbor 1.341
Beijing 961
New York 803
Roxbury 665
Lawrence 661
Lauterbourg 647
Nanjing 615
Rome 615
Los Angeles 578
Dallas 482
Bari 437
Des Moines 418
Helsinki 399
São Paulo 324
Princeton 322
Ho Chi Minh City 304
Inglewood 276
Santa Clara 274
Brooklyn 268
Munich 265
Council Bluffs 257
Boardman 219
Buffalo 210
San Diego 203
Abidjan 164
Hanoi 164
London 161
Shenyang 158
Chicago 155
Columbus 155
Figino 155
Nanchang 155
Dearborn 149
Hebei 137
Turin 132
Brussels 129
Frankfurt am Main 128
Jakarta 128
Falkenstein 126
Jiaxing 125
Tokyo 113
Dublin 106
Tianjin 106
Johannesburg 103
Moscow 103
Orem 102
Warsaw 96
Montreal 94
Tashkent 92
Rio de Janeiro 91
Toronto 91
Baghdad 86
Denver 85
Grafing 84
Belo Horizonte 81
Changsha 81
Atlanta 80
Dong Ket 77
Naples 77
Washington 77
Chennai 75
Pune 73
Marseille 71
Dhaka 70
Paris 70
Stockholm 67
Guangzhou 66
Phoenix 66
Nuremberg 62
Redwood City 61
The Dalles 60
Mexico City 58
San Francisco 58
Curitiba 57
Manchester 57
Turku 56
Amsterdam 54
Boston 54
Brasília 54
Porto Alegre 52
Salvador 48
Amman 47
Florence 47
Bologna 46
Guayaquil 46
Lahore 45
Totale 52.160
Nome #
Uridine and pyruvate protect T cells’ proliferative capacity from mitochondrial toxic antibiotics: a clinical pilot study 464
Significato clinico dell’interleuchina-2 (IL-2) e del suo recettore solubile nelle gammapatie monoclonali e nella crioglobulinemia mista essenziale 402
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 297
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability 253
Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy 250
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression 246
A Mini-Review on Thalidomide: Chemistry, Mechanisms of Action, Therapeutic Potential and Anti-Angiogenic Properties in Multiple Myeloma 245
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 223
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 223
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 216
18F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders 212
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies 207
Isolation and characterization of neural stem cells from dystrophic mdx mouse 204
Analysis of aortic remodeling and stiffness in patients with obstructive sleep apnea syndrome: Preliminary results 204
Le tecniche immunoenzimatiche in immunoistochimica. L’immunoperossidasi e l’immunofosfatasi alcalina 197
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 196
Role of endothelial cells and fibroblasts in multiple myeloma angiogenic switch 195
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets 194
A new image analysis method based on topological and fractal parameters to evaluate the angiostatic activity of docetaxel by using the matrigel assay in vitro 193
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 193
Role of HDL and uric acid in vascular damage in well-controlled 191
Mucine-1 is related to cell-mediated immunoexpression and blood pressure in pulmonary artery in pulmonary arterial hypertension (PAH): Preliminary results 191
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese" 191
Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma 190
Multiple myeloma macrophages: Pivotal players in the tumor microenvironment 190
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial 190
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 190
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 189
The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein 188
A possible role of tryptase in angiogenesis in the brain of mdx mouse, a model of Duchenne muscular dystrophy 187
Microenvironment drug resistance in multiple myeloma: Emerging new players 186
Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review) 186
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 185
JAM-A as a Prognostic Factor and New Therapeutic Target in Multiple Myeloma 185
Extramedullary Plasmacytoma Mimicking Pancreatic Cancer: An Unusual Presentation 184
HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma 184
Functional and biological role of endothelial precursor cells in tumour progression: A new potential therapeutic target in haematological malignancies 183
Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality 183
Identify multiple myeloma stem cells: Utopia? 182
Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression 180
Management of common variable immunodeficiency by subcutaneous IgG self-administration during pregnancy - a case report 180
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles. 180
Evidence for bone marrow adult stem cell plasticity: Properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation 180
Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies 180
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 179
Halting prosurvival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes Bortezomid resistance in multiple myeloma patients. 176
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing 176
Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections 175
Targeting B-cell non Hodgkin lymphoma: New and old tricks 174
Giant cell arteritis: The experience of two collaborative referral centers and an overview of disease pathogenesis and therapeutic advancements 174
Dendritic cell maturation in HCV infection: Altered regulation of MHC class I antigen processing-presenting machinery 173
Phthalimide Derivative Shows Anti-angiogenic Activity in a 3D Microfluidic Model and No Teratogenicity in Zebrafish Embryos 173
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 173
MHC Class i Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells 171
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients 171
Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea 170
A multiple myeloma that progressed as type i cryoglobulinemia with skin ulcers and foot necrosis: A case report 169
Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients 168
Neutropenia and G-CSF in lymphoproliferative diseases 165
Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center 164
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 164
Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: In vitro and in vivo studies 163
A favorable response to omalizumab in a patient with cheilitis granulomatosa 162
“miRNAs profile of bone marrow fibroblasts in multiple myeloma: relationship with disease progression and drug-resistance” 162
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 162
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma 161
Correlations between severity of obstructive sleep apnoea and systolic pulmonary artery pressure: preliminary results 160
Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma 158
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients 158
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27 158
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype 158
Involvement of NOTCH signaling in multiple myeloma angiogenesis and progression 157
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 157
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass 157
Intelligent microarray data analysis through non-negative matrix factorization to study human multiple myeloma cell lines 156
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme 155
Hemilipin, a novel Hemiscorpius lepturus venom heterodimeric phospholipase A2, which inhibits angiogenesis in vitro and in vivo 155
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 155
Efficacy and safety of benralizumab in eosinophilic granulomatosis with polyangiitis: A meta‐analysis of eight studies 154
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 154
90y-ibritumomab tiuxetan as consolidation therapy after autologous stem cell trasplantation in aggressive non-Hodgkin lymphoma 154
Bortezomib treatment modulates autophagy in multiple myeloma 154
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target 154
Cryptpogenic stroke: the complex interplay between endothelial dysfunction and interatrial defects orchestred by MTHFR mutation 152
A comprehensive biological and clinical perspective can drive a patient-tailored approach to multiple myeloma: Bridging the gaps between the plasma cell and the neoplastic niche 152
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer 150
Jejunal overexpression of peptide YY in celiac disease complicated with pneumatosis cystoides intestinalis 150
Acute intratoracic gastric volvulus from a diaphragmatic hernia after left splenopancreatectomy: report of a case 150
A case of Cogan's syndrome resolved with mycophenolate sodium 150
Dizionario degli eponimi clinici 149
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs 149
Anti Th/To autoantibodies: a predictor markers for interstitial lung disease in undifferentiated connective tissue disease at risk of systemic sclerosis 149
Angiogenesis and anti-angiogenesis in neuroblastoma 148
Pharmacological activation of protein phosphatase 2 A (PP2A): A novel strategy to fight against human malignancies? 148
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 148
Targeting vasculogenesis to prevent progression in multiple myeloma 147
Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience 146
A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agents 146
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 146
The COVID-19 Stress Perceived on Social Distance and Gender-Based Implications 145
Totale 18.173
Categoria #
all - tutte 338.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 338.132


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.965 301 658 73 208 246 285 283 268 298 372 812 1.161
2022/20238.026 1.184 875 501 743 855 1.159 87 822 1.402 66 180 152
2023/20243.018 253 540 167 183 279 903 92 150 17 76 44 314
2024/202512.101 337 192 1.068 473 338 1.002 1.047 1.123 554 661 1.778 3.528
2025/202625.721 3.545 974 1.386 2.568 2.743 1.604 2.990 816 2.529 2.282 983 3.301
2026/2027934 934 0 0 0 0 0 0 0 0 0 0 0
Totale 79.845